Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Antibody Design logo — Leading-edge research at the interface of deep tech and biot...

Antibody Design

Leading-edge research at the interface of deep tech and biotechnology to deliver unparalleled innovation

Founded 2022 United Kingdom London, United Kingdom 1 employees Seed Total: $150.00K

General Information

Company Name Antibody Design
Founded Year 2022
Location United Kingdom London, United Kingdom
Employees 1
Funding Stage Seed
Business Model B2B, D2C
Revenue Model Product Sales, Service Fee, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Antibody Design. To contact Antibody Design, visit antibodydesign.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Antibody Design compare?

A PDF of Antibody Design and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Antibody Design soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Antibody Design

Antibody Design is a young and innovative biotech startup, founded in 2022, and headquartered in the United Kingdom. The company operates at the cutting edge of deep tech and biotechnology, aiming to revolutionize the field with their next-generation, AI-driven rapid diagnostics capabilities. Their aspiration is to merge technology and biology to create smarter, more connected healthcare solutions.

Despite its infancy, Antibody Design has already caught the attention of early-stage investors, securing an investment of £150.00K from SFC Capital in an Early VC round on 01 June 2023. This funding signifies investor confidence in their potential to disrupt the biotech industry with groundbreaking innovation.

With its strategic focus and recent infusion of capital, Antibody Design is positioned to leverage advancements in AI and biotechnology, offering compelling growth and partnership opportunities for forward-thinking investors.

Business keywords: deep tech, AI-driven diagnostics, smart diagnostics, connected diagnostics, rapid diagnostics, biotech startup, innovation, diagnostic technology, AI in healthcare, health technology, biotech innovation

Services & Products

next-generation diagnostic solutions
antibody-based technology
biological research and development

Target Customers

healthcare providers research institutions clinical laboratories biotech companies

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC £150.00K 1
SFC Capital
SFC Capital
01 Jun 2023

Antibody Design Alternatives & Competitors

View All Alternatives
Antibody Design vs
Thrixen
Thrixen Singapore

Unlocking the next generation of simple, affordable & accessible diagnostics

Venture round
10 employees
Biotechnology, Health Care
Antibody Design vs
ExcepGen
ExcepGen United States

Solving fundamental problems in drug discovery to create a new generation of therapeutics.

Seed
3 employees
Biopharma, Biotechnology
Antibody Design vs
Nuclera
Nuclera United Kingdom

Bring rapid protein access to your benchtop with eProtein Discovery

Series C
108 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About Antibody Design

Leading-edge research at the interface of deep tech and biotechnology to deliver unparalleled innovation
Antibody Design was founded in 2022.
Antibody Design is headquartered in London, United Kingdom.
Antibody Design has a B2B and D2C business model. Its revenue comes from Product Sales, Service Fee and Licensing.
Antibody Design has approximately 1 employees.
Antibody Design has completed 1 funding round, raising a total of $150.00K. The latest funding stage is Seed.
Antibody Design offers: next-generation diagnostic solutions, antibody-based technology, biological research and development.
Top alternatives and competitors to Antibody Design include Thrixen, ExcepGen, Nuclera, Magnisense, Leyi Biology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Antibody Design and Thrixen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Antibody Design, https://bouncewatch.com/company/antibody-design, updated 12 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout